Driehaus Capital Management’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$725K Buy
+21,567
New +$931K 0.01% 385
2025
Q3
– Sell
-131,340
Closed -$1.49M – 521
2025
Q2
$1.49M Buy
+131,340
New +$1.39M 0.01% 345

Other funds holding RAPP

Driehaus Capital Management's RAPP Position: Q3 2026 in Review

Driehaus Capital Management opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 21,567 shares worth $725K. The stake represents 0.01% of the portfolio and ranks #385 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in RAPP as recently as Q2 2025.

Driehaus Capital Management first reported a position in RAPP in Q2 2025 and has held it in 2 quarters since. The position peaked at $1.49M in Q2 2025. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Driehaus Capital Management held 21,567 shares of Rapport Therapeutics worth $725K as of Q3 2026.
  • Rapport Therapeutics was a new Driehaus Capital Management position in Q3 2026.
  • Rapport Therapeutics made up 0.01% of Driehaus Capital Management's portfolio in Q3 2026, its #385 holding.
  • Driehaus Capital Management first reported a position in Rapport Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • Driehaus Capital Management's Rapport Therapeutics position peaked at $1.49M in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.